Free Widgets | Feedback 
Live Share Markets - Appuonline.com


Updated:24 Apr 2017 03:31:00 PM(IST)

Investor Tool

My Stockwatch 

RELIANCE 1417.40 [ +1.06% ]TCS 2328.10 [ +0.75% ]

Sensex29655.84
290.54 0.99%

Nifty9217.95
98.55 1.08%

Midcap14625.73
137.81 0.95%

Smallcap15291.26
124.95 0.82%



Aurobindo Pharma Ltd :

 628.95  -4.35 [-0.69%]

ISIN: INE406A01037  | NSE: AUROPHARMA |  Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln  |  BSE Code: 524804  |  Add To Watchlist

Price Information
• Open 634.00
• High 634.00
• Low 626.20
• Previous Close 633.30
• Shares Traded 10657400
• 52 Wk High Price 895.00
• 52 Wk High Date 06-10-2016
• 52 Wk Low Price 622.00
• 52 Wk Low Date 26-12-2016
• Face Value 1.00


Fundamentals
• Market Capital (Rs.cr) 37508.20
• EPS (Rs.)(TTM) 28.31
• P/E Ratio(TTM) 22.61
• Book Value (Rs.) 116.20
• Price to Book Value 5.51
• Equity (Rs.cr.) 58.59
• Traded Value (Rs.lac) 2354.74


Corporate Actions
Ex-Date Purpose (Rs.)
2010-11-11 100% Interim Dividend (5)
2011-02-10 Stock Split from Rs.5 to Rs.1 (0)
2011-07-20 100% Final Dividend (1)
2012-07-30 100% Dividend (1)
2013-02-18 100% Interim Dividend (1)
2013-07-30 50% Final dividend (0.5)
2013-11-19 125% Interim Dividend (1.25)
2014-06-11 175% Second Interim Dividend (1.75)
2014-08-13 150% Interim Dividend (1.5)
2015-02-16 200% Interim Dividend (2)
2015-06-08 1003rd Interim Dividend (100)
2015-07-20 1:1 Bonus Issue of Equity Shares (0)
2015-08-21 50% Interim Dividend (0.5)
2015-11-19 60% Interim Dividend (0.6)
2016-02-18 70% Third Interim Dividend (0.7)
2016-06-09 4th 70% Interim Dividend (0.7)
2016-06-09 70% 4th Interim Dividend (0.7)
2016-11-24 125% Interim Dividend (1.25)


Index Names
CNX Nifty
BSE-200
BSE HC
BSE-500
BSE-100


Related Companies
Stock Name Price
BAJAJTEMPO 4668.10




Key Financials Latest Qrtr. Trailing Yr. Full Yr.
• Year End Dec, 2016 Dec, 2016 Mar, 2016
• Sales (Rs.cr) 2460.35 9641.07 9166.18
• Net Profit (Rs.cr) 441.02 1658.43 1620.48
• Net Profit Var (%) -5.00 7.00 7.00
• EPS (Rs) - 28.31 27.20
• P/E Ratio - 22.61 23.50
• Operating Profit Margin - 24.91 -
• CPS (Rs.) - - 31.60
• P/C Ratio - - 20.20
• Div% - - 250.00

Announcements
06-02-2015 Board of Aurobindo Pharma recommends dividend
02-06-2016 Board of Aurobindo Pharma recommends final dividend
10-02-2016 Board of Aurobindo Pharma recommends third interim dividend
10-08-2013 Aurobindo Pharma follows acquisitions through subsidiaries On 09 August 2013
12-10-2012 Aurobindo Pharma received tentative approval for the Risedronate Sodium tablets
28-06-2013 Aurobindo Pharma receives Tentative Approval for Efavirenz+Lamivudine+ Tenofovir Disoproxil Fuma
06-08-2012 Aurobindo Pharma receives final approvals for Montelukast Sodium tablets and Chewable tablets
02-07-2013 Aurobindo Pharma receives USFDA approval for Rizatriptan Benzoate Orally Disintegrating Tablets
10-02-2017 Aurobindo Pharma acquires four products from TL Biopharmaceutical AG
11-02-2012 Aurobindo Pharma adjourns board meeting
10-03-2017 Aurobindo Pharma allots 6,97,823 equity shares
30-12-2010 Aurobindo Pharma allots equity shares
05-12-2014 Aurobindo Pharma announces completion of acquisition of Natrol
07-01-2017 Aurobindo Pharma announces plans to acquire Generis Farmaceutica SA in Portugal
19-01-2012 Aurobindo Pharma appoints additional director
22-11-2012 Aurobindo Pharma appoints CEO
25-03-2015 Aurobindo Pharma appoints director
03-11-2010 Aurobindo Pharma declares interim dividend
07-09-2011 Aurobindo Pharma establishes a joint venture company with Diod (Russia)
05-02-2015 Aurobindo Pharma fixes record date for 2nd interim dividend
09-12-2015 Aurobindo Pharma gets ANDA approval for Eptifibatide Injection
06-01-2015 Aurobindo Pharma gets approval to launch Valsartan Tablets
16-09-2014 Aurobindo Pharma gets final approval for Amoxicillin for Oral Suspension
27-08-2015 Aurobindo Pharma gets final approval for Entecavir Tablets, 0.5mg and 1mg
27-07-2015 Aurobindo Pharma gets final approval for Esmolol Hydrochloride Injection
22-04-2016 Aurobindo Pharma gets final approval for Esomeprazole Magnesium Delayed-release Capsules
03-02-2016 Aurobindo Pharma gets final approval for Isosulfan Blue Injection
29-04-2016 Aurobindo Pharma gets final approval for Lascoamide Tablets
19-03-2016 Aurobindo Pharma gets final approval for Naproxen Sodium Tablets (OTC)
22-12-2015 Aurobindo Pharma gets final approval for Olopatadine Hydrochloride Ophthalmic Solution
31-03-2016 Aurobindo Pharma gets final approval for Pantoprazole Sodium for Injection
01-04-2016 Aurobindo Pharma gets final approval for Vancomycin Hydrochloride for Injection
06-12-2011 Aurobindo Pharma gets UK MHRA nod for the Bisoprol Fumarate tablets
25-11-2011 Aurobindo Pharma gets UK MHRA nod for the Cefpodoxime Proxetil tablets
16-12-2011 Aurobindo Pharma grants options
07-09-2012 Aurobindo Pharma received final approval for the Generic Lotrel
21-11-2011 Aurobindo Pharma received final approval for the Lamivudine tablets
01-12-2015 Aurobindo Pharma receives ANDA approval for Risedronate Sodium Tablets
02-12-2015 Aurobindo Pharma receives ANDA final approval for Dexamethasone Sodium Phosphate Injection
11-01-2016 Aurobindo Pharma receives ANDA final approval for Norethindrone Acetate Tablets
06-04-2015 Aurobindo Pharma receives approval for Sildenafil Injection
18-05-2011 Aurobindo Pharma receives approvals for Risperidone tablets, oral solution & Alendronate tablets fr
09-10-2015 Aurobindo Pharma receives final approval for Aripiprazole Tablets
09-04-2015 Aurobindo Pharma receives final approval for Atracurium Besylate Injections
18-03-2016 Aurobindo Pharma receives final approval for Dexmedetomidine Hydrochloride Injection
06-05-2016 Aurobindo Pharma receives final approval for Fenofibrate Tablets
10-07-2015 Aurobindo Pharma receives final approval for Flecainide Acetate Tablets
16-05-2012 Aurobindo Pharma receives final approval for Lamivudine & Zidovudine tablets
08-08-2016 Aurobindo Pharma receives final approval for Linezolid Injection
17-12-2015 Aurobindo Pharma receives final approval for Loperamide Hydrochloride Tablet
26-04-2012 Aurobindo Pharma receives final approval for Olanzapine Tablets
27-04-2016 Aurobindo Pharma receives final approval for Oxymorphone Hydrochloride Tablets
05-04-2016 Aurobindo Pharma receives final approval for Polymyxin B for Injection
20-07-2016 Aurobindo Pharma receives final approval for Rosuvastatin Calcium Tablets
29-03-2012 Aurobindo Pharma receives final approvals for Quetiapine Fumarate tablets
30-04-2013 Aurobindo Pharma Receives USFDA Approval for Quinapril Tablets
30-05-2012 Aurobindo Pharma recommends final dividend
09-05-2012 Aurobindo Pharma to announce financial results
27-07-2011 Aurobindo Pharma to announce Q1 results
31-10-2011 Aurobindo Pharma to announce Q2 results
25-01-2011 Aurobindo Pharma to announce Q3 results
21-05-2012 Aurobindo Pharma to consider dividend
29-10-2010 Aurobindo Pharma to consider interim dividend
26-11-2010 Aurobindo Pharma to convene EGM
02-08-2016 Aurobindo Pharma to hold AGM
05-11-2013 Aurobindo Pharma to hold board meeting
23-12-2014 Aurobindo Pharma to hold EGM
08-08-2014 Board of Aurobindo Pharma approves interim dividend
11-12-2014 Board of Aurobindo Pharma approves raising funds through QIP issue
25-11-2014 Board of Aurobindo Pharma considers fund raising proposal
13-08-2012 P L Sanjeev Reddy ceases as director of Aurobindo Pharma

Gross Deliverables
Date Del. Shares Trd. Qty. Del.(%) Del. Value Turnover
21-04-2017 54000 232941 23.18 34198200 147974.00
20-04-2017 73152 261294 28.00 46392999 166416.00
19-04-2017 78440 362917 21.61 50217288 235474.00
18-04-2017 49312 266186 18.53 32723444 177533.00
17-04-2017 26722 72386 36.92 17437442 47313.60


Note:

- % change is w.r.t. Prev. Close
- On ex-date % change is w.r.t. open price
- On the date ofmovement of security from/to trade for trade segment, % change is w.r.t. open price
- 52 week high & 52 week low prices are based on the trade date & not adjusted with corporate action




Market on Mobile



Hot Searches  •  tata mot  •  nutraplus india  •  housing  •  tvs motor company  •  zee ent
Site Map  •  Companies  •  Learning Centre  •  Insurance  •  About  •  Contact us  •  Disclaimer
© appuonline.com

Content Provided by CMOTS InfoTech